Company intelligence / Profile preview

OvaGene Oncology

Irvine, California, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

OvaGene Oncology develops and commercializes molecular diagnostic assays for women with gynecologic cancers. Their marketed products provide quantitative gene expression analysis to guide therapy selection, aiming to improve outcomes by personalizing treatment choices. The company has launched several proprietary tests regionally in the US and Korea, with ongoing validation studies at leading academic centers. They also offer a blood test ("OvaTOX") to predict genetic risk of chemotherapy toxicities.

Therapeutic areas: OncologyWomen's Health
Modalities: Diagnostic assay (gene-based/molecular diagnostics)
Industry: Molecular Diagnostics

Partnerships

Licensing agreements with Norwegian academic researchers including University of Bergen Tech Office BTO for genomic technologies related to endometrial/cervical cancer testing.

Beyond the preview

Go deeper on OvaGene Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OvaGene Oncology.

Explore the full profile